Growth Inhibition of Colon Cancer Cells by Compounds Affecting Ampk Activity

World Journal of Gastrointestinal Oncology

Volumn 6, Issue , 2014, Pages 244-252

  Lea, Michael A ^a   Pourat, Jacob ^a   Patel, Rupali ^a   DesBordes, Charles ^a,b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

AMPdependent; Colon cancer cells; Glucose metabolism; Proliferation; protein kinase

Indexed keywords

EID: 84936744833     PISSN: None     EISSN: 19485204     Source Type: Journal    
DOI: 10.4251/wjgo.v6.i7.244     Document Type: Article

References (25)

1. 1 Lea MA, Chacko J, Bolikal S, Hong JY, Chung R, Ortega A, desBordes C. Addition of 2-deoxyglucose enhances growth inhibition but reverses acidification in colon cancer cells treated with phenformin. Anticancer Res 2011; 31: 421-426 [PMID: 21378320]
2. 2 Lea MA, Qureshi MS, Buxhoeveden M, Gengel N, Klein- schmit J, desBordes C. Regulation of the proliferation of colon cancer cells by compounds that affect glycolysis, in¬cluding 3-bromopyruvate, 2-deoxyglucose and biguanides. Anticancer Res 2013; 33: 401-407 [PMID: 23393330]
3. 3 Hardie DG. AMPK: a target for drugs and natural products with effects on both diabetes and cancer. Diabetes 2013; 62: 2164-2172 [PMID: 23801715 DOI: 10.2337/db13-0368]
4. 4 Hardie DG, Alessi DR. LKB1 and AMPK and the cancer-me¬ tabolism link - ten years after. BMC Biol 2013; 11: 36 [PMID: 23587167 DOI: 10.1186/1741-7007-11-36]
5. 5 Pollak M. Potential applications for biguanides in oncol¬ogy. J Clin Invest 2013; 123: 3693-3700 [PMID: 23999444 DOI: 10.1172/JCI67232]
6. 6 Quinn BJ, Kitagawa H, Memmott RM, Gills JJ, Dennis PA. Repositioning metformin for cancer prevention and treat¬ment. Trends Endocrinol Metab 2013; 24: 469-480 [PMID: 23773243 DOI: 10.1016/j.tem.2013.05.004]
7. 7 Goransson O, McBride A, Hawley SA, Ross FA, Shpiro N, Foretz M, Viollet B, Hardie DG, Sakamoto K. Mechanism of action of A-769662, a valuable tool for activation of AMP- activated protein kinase. J Biol Chem 2007; 282: 32549-32560 [PMID: 17855357 DOI: 10.1074/jbc.M706536200]
8. 8 Sakamoto K, Goransson O, Hardie DG, Alessi DR. Activity of LKB1 and AMPK-related kinases in skeletal muscle: ef¬fects of contraction, phenformin, and AICAR. Am J Physiol Endocrinol Metab 2004; 287: E310-E317 [PMID: 15068958 DOI: 10.1152/ajpendo.00074.2004]
9. 9 Park SY, Lee YK, Kim YM, Park OJ and Shin JI. Control of AMPK-activated protein kinase, Akt, and mTOR in EGCG- treated HT-29 colon cancer cells. Food Sci Biotech 2013; 22: 147-151 [DOI: 10.1007/s10068-013-0020-1]
10. 10 Zakikhani M, Bazile M, Hashemi S, Javeshghani S, Avizo- nis D, St Pierre J, Pollak MN. Alterations in cellular energy metabolism associated with the antiproliferative effects of the ATM inhibitor KU-55933 and with metformin. PLoS One 2012; 7: e49513 [PMID: 23185347 DOI: 10.1371/journal. pone.0049513]
11. 11 Hardie DG. Sensing of energy and nutrients by AMP-activat¬ed protein kinase. Am J Clin Nutr 2011; 93: 891S-8916 [PMID: 21325438 DOI: 10.3945/ajcn.110.001925]
12. 12 Hayakawa N, Shiozaki M, Shibata M, Koike M, Uchiyama Y, Matsuura N, Gotow T. Resveratrol affects undifferentiated and differentiated PC12 cells differently, particularly with respect to possible differences in mitochondrial and autoph¬agic functions. Eur J Cell Biol 2013; 92: 30-43 [PMID: 23141968 DOI: 10.1016/j.ejcb.2012.10.002]
13. 13 Hawley SA, Fullerton MD, Ross FA, Schertzer JD, Chevtzoff C, Walker KJ, Peggie MW, Zibrova D, Green KA, Mustard KJ, Kemp BE, Sakamoto K, Steinberg GR, Hardie DG. The ancient drug salicylate directly activates AMP-activated pro¬tein kinase. Science 2012; 336: 918-922 [PMID: 22517326 DOI: 10.1126/science.1215327]
14. 14 Vichai V, Kirtikara K. Sulforhodamine B colorimetric as¬say for cytotoxicity screening. Nat Protoc 2006; 1: 1112-1116 [PMID: 17406391 DOI: 10.1038/nprot.2006.179]
15. 15 Cool B, Zinker B, Chiou W, Kifle L, Cao N, Perham M, Dickin¬son R, Adler A, Gagne G, Iyengar R, Zhao G, Marsh K, Kym P, Jung P, Camp HS, Frevert E. Identification and character¬ization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab 2006; 3: 403-416 [PMID: 16753576 DOI: 10.1016/j. cmet.2006.05.005]
16. 16 Corton JM, Gillespie JG, Hawley SA, Hardie DG. 5-ami- noimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 1995; 229: 558-565 [PMID: 7744080 DOI: 10.1111/j.1432-1033.1995.tb20498.x]
17. 17 Kim HS, Wannatung T, Lee S, Yang WK, Chung SH, Lim JS, Choe W, Kang I, Kim SS, Ha J. Quercetin enhances hypoxia- mediated apoptosis via direct inhibition of AMPK activity in HCT116 colon cancer. Apoptosis 2012; 17: 938-949 [PMID: 22684842 DOI: 10.1007/s10495-012-0719-0]
18. 18 Kim MY, Lim JH, Youn HH, Hong YA, Yang KS, Park HS, Chung S, Ko SH, Shin SJ, Choi BS, Kim HW, Kim YS, Lee JH, Chang YS, Park CW. Resveratrol prevents renal lipotox- icity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1a axis in db/db mice. Diabetologia 2013; 56: 204-217 [PMID: 23090186 DOI: 10.1007/ s00125-012-2747-2]
19. 19 Skrobuk P, von Kraemer S, Semenova MM, Zitting A, Koi¬stinen HA. Acute exposure to resveratrol inhibits AMPK activity in human skeletal muscle cells. Diabetologia 2012; 55: 3051-3060 [PMID: 22898769 DOI: 10.1007/s00125-012-2691-1]
20. 20 Viollet B, Horman S, Leclerc J, Lantier L, Foretz M, Billaud M, Giri S, Andreelli F. AMPK inhibition in health and disease. Crit Rev Biochem Mol Biol 2010; 45: 276-295 [PMID: 20522000 DOI: 10.3109/10409238.2010.488215]
21. 21 Din FV, Valanciute A, Houde VP, Zibrova D, Green KA, Sakamoto K, Alessi DR, Dunlop MG. Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and in¬duces autophagy in colorectal cancer cells. Gastroenterology 2012; 142: 1504-1505.e3 [PMID: 22406476 DOI: 10.1053/j.gas- tro.2012.02.050]
22. 22 Munding J, Ziebarth W, Pox CP, Ladigan S, Reiser M, Huppe D, Brand L, Schmiegel W, Tannapfel A, Reinacher- Schick AC. The influence of 5-aminosalicylic acid on the pro¬gression of colorectal adenomas via the p-catenin signaling pathway. Carcinogenesis 2012; 33: 637-643 [PMID: 22198215 DOI: 10.1093/carcin/bgr306]
23. 23 Kourelis TV, Siegel RD. Metformin and cancer: new applica¬tions for an old drug. Med Oncol 2012; 29: 1314-1327 [PMID:21301998 DOI: 10.1007/s12032-011-9846-7]
24. 24 Rizos CV, Elisaf MS. Metformin and cancer. Eur J Phar¬macol 2013; 705: 96-108 [PMID: 23499688 DOI: 10.1016/j. ejphar.2013.02.038]
25. 25 Russo GL, Russo M, Ungaro P. AMP-activated protein kinase: a target for old drugs against diabetes and cancer. Biochem Pharmacol 2013; 86: 339-350 [PMID: 23747347 DOI: 10.1016/j. bcp.2013.05.023]